Breaking News Instant updates and real-time market news.

F

Ford

$8.51

-0.01 (-0.12%)

, GM

General Motors

$36.76

0.25 (0.68%)

07:30
03/26/19
03/26
07:30
03/26/19
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Monday in Ford (F), General Motors (GM), Oracle (ORCL), McDermott (MDR), News Corp. (NWSA), CarMax (KMX), and Lexicon Pharmaceuticals (LXRX).

F

Ford

$8.51

-0.01 (-0.12%)

GM

General Motors

$36.76

0.25 (0.68%)

ORCL

Oracle

$52.72

-0.07 (-0.13%)

MDR

McDermott

$7.02

-0.085 (-1.20%)

NWSA

News Corp.

$12.56

-0.07 (-0.55%)

KMX

CarMax

$61.60

0.64 (1.05%)

LXRX

Lexicon

$5.66

-0.63 (-10.02%)

  • 27

    Mar

  • 29

    Mar

  • 25

    Apr

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 25

    Jun

  • 24

    Jul

  • 23

    Oct

F Ford
$8.51

-0.01 (-0.12%)

02/13/19
GHSC
02/13/19
INITIATION
GHSC
Neutral
Ford initiated with a Neutral at Seaport Global
02/13/19
GHSC
02/13/19
INITIATION
GHSC
Neutral
Ford initiated with a Neutral on valuation at Seaport Global
Seaport Global analyst Michael Ward initiated Ford with a Neutral citing valuation and said the company's current financial position will make it difficult to get concessions and keep shares range bound.
02/20/19
MSCO
02/20/19
NO CHANGE
Target $10
MSCO
Equal Weight
Morgan Stanley would fade Ford rally on SA heavy truck exit news
After Ford announced yesterday that it will exit the commercial heavy truck business in South America and expects to record pre-tax special item charges of about $460M as a result, Morgan Stanley analyst Adam Jonas said he would fade the rally following the news given that he sees the situation as "highly volatile." Ford's restructuring efforts help address its negatively valued business in South America, but some investors may have hoped for more significant actions, added Jonas, who keeps an Equal Weight rating on Ford with a $10 price target.
03/01/19
UBSW
03/01/19
NO CHANGE
Target $10
UBSW
Buy
Enormity of strategic shift at Ford not appreciated by investors, says UBS
UBS analyst Colin Langan noted Ford investors are growing impatient with the company's "Fitness" plan, given limited results and sparse concrete details. The analyst believes the enormity of the strategic shift is underappreciated by investors as the company moves from low margin generalist to high margin specialist. Langan reiterated his Buy rating and $10 price target on Ford shares.
GM General Motors
$36.76

0.25 (0.68%)

02/13/19
GHSC
02/13/19
INITIATION
Target $48
GHSC
Buy
General Motors initiated with a Buy at Seaport Global
Seaport Global analyst Michael Ward initiated General Motors with a Buy and $48 price target.
03/13/19
MSCO
03/13/19
NO CHANGE
MSCO
Overweight
Morgan Stanley would be less surprised by GM's Cruise scaling back than growing
Following a recent Reuters report that said General Motors' (GM) Cruise unit plans to add 1,000 team members to double its headcount by year-end, Morgan Stanley analyst Adam Jonas said he would have been less surprised if Cruise was scaling back its growth plans rather than accelerating them given what he sees as "a general stalling" of autonomous vehicle expectations. His understanding is that the technology required to remove human drivers at an acceptable level of safety is likely many years away, said Jonas, who added that "it really matters" what Amazon (AMZN) is doing and whether it becomes a potential partner with GM, a competitor, or both. He maintains an Overweight rating on GM shares.
02/19/19
NOMU
02/19/19
UPGRADE
NOMU
Buy
Honda upgraded to Buy on plant closures at Nomura Instinet
As previously reported, Nomura Instinet analyst Masataka Kunugimoto upgraded Honda (HMC) to Buy from Neutral as he believes auto plant closures will prompt a reassessment of the company's strong balance sheet and motorcycle operations. The analyst likes its more flexible management approach, as evidenced by the moves to strengthen its partnership with General Motors (GM) in next-generation technologies. He also commends the tough decision it has taken to close plants in the U.K. and Turkey in 2021, in addition to the previous decision to close the Sayama plant in Japan, which it announced in October 2017. Kunugimoto expects reductions in fixed costs and production costs per vehicle as a result of these plant closures to boost operating profits. The analyst raised his price target on Honda shares to JPY3,850 from JPY3,014.
02/13/19
GHSC
02/13/19
INITIATION
Target $48
GHSC
Buy
Seaport Global starts General Motors at Buy, says 'not your father's GM'
Seaport Global analyst Michael Ward initiated General Motors with a Buy rating , stating that GM has become a "completely different company" and "not your father's GM" over the last 10 years. In that span, it has sold its European auto operations; overhauled the relationship with U.S. unions; expanded GM Financial; become a leader in China; updated its entire portfolio; and established the company as a global leader in autonomous driving, Ward stated. The auto and tech worlds are converging and GM could be the best positioned global auto maker for developing industry trends, said Ward, who set a $48 price target on the shares.Target $48.
ORCL Oracle
$52.72

-0.07 (-0.13%)

03/15/19
JMPS
03/15/19
NO CHANGE
JMPS
Market Perform
JMP Securities questions if Ellison might want to take Oracle private
After Oracle reported better than expected Q3 results and guided to as reported revenue growth in Q4 that was below the consensus, JMP Securities analyst Patrick Walravens cited "a number of factors" that make him wonder whether Larry Ellison "might be slowly moving toward taking Oracle private." Among them he lists the company's aggressive share buybacks, which he notes are driving Ellison's beneficial ownership of the common stock higher as a percentage of the class; the fact that several industry sources have recently told him Ellison is more engaged now than he has been in several years; and Ellison's remarks in 2015 about how "brilliant" Michael Dell and Jim Davidson were for taking Dell private and then buying EMC. Despite his questioning about whether Ellison would like to take Oracle private, Walravens maintain a Market Perform rating on Oracle shares.
03/15/19
RBCM
03/15/19
NO CHANGE
Target $57
RBCM
Sector Perform
Oracle price target raised to $57 from $55 at RBC Capital
RBC Capital analyst Ross MacMillan raised his price target on Oracle to $57 after its Q3 earnings beat driven by operating expense controls and buybacks but also kept his Sector Perform rating due to "lackluster" revenue performance. The analyst notes that the company's "weak billings" implies no top-line acceleration this year, adding that while he continues to look for faster growth in the Cloud segment and a pick-up from Autonomous segment growth, he sees "no reason" to change his view at this time.
03/15/19
03/15/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Oracle (ORCL) downgraded to Market Perform from Outperform at BMO Capital with analyst Keith Bachman saying he believes Oracle can sustain ~2% constant currency revenue growth, but is "dubious" the company can improve its revenue growth rates. 2. Zillow (ZG, Z) downgraded to Underweight from Equal Weight at Barclays with analyst Deepak Mathivanan citing his expectations for a "material erosion" in unit economics in its Homes division, the operational challenges facing the company in buying, fixing up, and selling homes at scale and the fact that he thinks the company's efforts to slowly transition its core PA business closer to transaction will keep revenue growth muted in the near-term. 3. State Street (STT) downgraded to Hold from Buy at Deutsche Bank with analyst Brian Bedell saying he no longer sees any near- or intermediate-term positive catalysts for the stock given the likely continued revenue growth pressures this year. 4. Live Nation (LYV) downgraded to Neutral from Buy at Citi with analyst Jason Bazinet saying he continues to like Live Nation's business model and long-term growth prospects, but he views the valuation as "full" at current share levels. 5. Adobe (ADBE) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brent Bracelin citing the company's fiscal Q1 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
DZBN
03/20/19
DOWNGRADE
DZBN
Sell
Oracle downgraded yesterday to Sell from Buy at DZ Bank
MDR McDermott
$7.02

-0.085 (-1.20%)

04/23/18
SBSH
04/23/18
NO CHANGE
SBSH
McDermott bid would need to be closer to $10/share to break CB&I deal, says Citi
Citi said Subsea 7's hostile bid for McDermott (MDR) for $7 per share was an interesting and unexpected move, but the firm believes any proposal would have to be closer to $10 per share to disrupt the current terms of the deal with CB&I (CBI), which it notes is well down the road toward closing. Citi's "strong sense" is that McDermott, with the support of a majority of its board, is intent on staying the course in closing the deal with CB&I, adding that it thinks McDermott is buying CB&I at or near the bottom of a backlog cycle.
10/31/18
KEYB
10/31/18
DOWNGRADE
KEYB
Sector Weight
McDermott downgraded to Sector Weight from Overweight at KeyBanc
NWSA News Corp.
$12.56

-0.07 (-0.55%)

01/14/19
SBSH
01/14/19
UPGRADE
SBSH
Buy
News Corp. upgraded to Buy from Neutral at Citi
Citi analyst David Kaynes upgraded News Corp. to Buy while lowering his price target for the shares to A$20 from A$21.45. The recent share price declines in the traditional Australian media stocks have been excessive, Kaynes tells investors in a research note. The analyst now sees value in the sector and upgraded a handful of names.
10/08/18
LOOP
10/08/18
NO CHANGE
Target $17
LOOP
Buy
News Corp valuation is attractive, says Loop Capital
Loop Capital analyst Alan Gould kept his Buy rating and $17 price target on News Corp, saying his latest discussions with the management suggest the company intends to continue allocating resources to its "high-growth digital real estate business". The analyst also expects News Corp to reorganize or sell Foxtel for more than it is being valued and also look at ongoing consolidation opportunities in book publishing. With the stock tracing at 7-times his expected FY18 EBITDA implied by 20-times multiple of the digital real-estate business, Gould sees the rest of the company valued at just 2.0- to 2.5-times EBITDA and recommends that investors take advantage of the opportunity.
10/09/18
GSCO
10/09/18
UPGRADE
GSCO
Buy
News Corp. upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Kane Hannan upgraded News Corp. to Buy and raised his price target for the shares to A$24.40 from A$22.40. Two thirds of the analyst's News Corp. valuation now resides in Digital Real Estate, a sector that he is "extremely positive on given the large addressable markets and significant scope for digital disruption." Hannan believes the market is not adequately reflecting the full value of REA and Move in News Corp.'s shares.
01/17/19
UBSW
01/17/19
UPGRADE
UBSW
Buy
News Corp. upgraded to Buy from Neutral at UBS
KMX CarMax
$61.60

0.64 (1.05%)

01/18/19
WEDB
01/18/19
DOWNGRADE
WEDB
Neutral
CarMax downgraded to Neutral from Outperform at Wedbush
01/07/19
BUCK
01/07/19
UPGRADE
Target $76
BUCK
Buy
CarMax upgraded to Buy from Neutral at Buckingham
Buckingham analyst Glenn Chin upgraded CarMax to Buy from Neutral, but cut its price target to $76 from $84 citing valuation. The analyst cannot discount concerns over intensifying competition and same-store unit cops, but said the 40M unit used vehicle market is sufficiently large enough and fragmented that it can support several large successful players. Chin also sees several catalysts to drive CarMax shares higher including continued earnings growth, abnormally strong used vehicle values, easing same-store comps, the nationwide roll-out of CarMax's omni-channel strategy, buybacks, and potentially reduced FED tightening.
01/18/19
WEDB
01/18/19
DOWNGRADE
Target $60
WEDB
Neutral
CarMax downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Seth Basham downgraded CarMax to Neutral from Outperform and lowered his price target to $60 from $70. In a research note to investors, Basham said he came away from the company's analyst meeting convinced that the company is committed to its omnichannel strategy, but believes the transition "will not be easy" due to deeply-rooted processes and behaviors that could be "disruptive" and "expensive" to change. Basham says it likely will neither be quick nor inexpensive for CarMax to change its weakened customer value perception in this highly competitive environment and also notes comps that continue to track well below consensus and weakening CAF performance trends.
03/25/19
BARD
03/25/19
NO CHANGE
Target $65
BARD
Outperform
Carvana price target raised to $65 from $58 at Baird
Baird analyst Colin Sebastian raised his price target for Carvana (CVNA) to $65 from $58 after increasing his Q1 unit and revenue estimates above consensus. The analyst now expects Q1 retail units of 34,000, above the consensus of 32,900, on revenue of $678M, up 88% year-over-year. Tax refund flows are likely to provide a late-quarter tailwind, Sebastian tells investors in a research note. The correlation between refunds and used car sales is likely providing a boost in unit sales ahead of the Q1 quarter close, Sebastian tells investors in a research note. Further, he believes the online shift by CarMax (KMX) and Tesla (TSLA) are endorsements of the e-commerce model. The analyst remains constructive on Carvana shares citing the momentum from a seasonal uplift in car sales, positive near-term data checks, and the "massive" long-term e-commerce opportunity for used cars. He keeps an Outperform rating on Carvana.
LXRX Lexicon
$5.66

-0.63 (-10.02%)

03/25/19
03/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Regions Financial (RF) upgraded to Buy from Hold at Sandler O'Neill with analyst Stephen Scouten saying he does not believe there is more than 3%-5% of potential downside to 2021 numbers if there are not a couple of Fed rate reductions in 2020. 2. TAL Education (TAL) and New Oriental Education (EDU) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. First Bancorp (FBNC) and MidSouth Bancorp (MSL) upgraded to Buy from Hold at Sandler O'Neill. 4. Lexicon (LXRX) upgraded to Hold from Sell at Gabelli with analyst Kevin Kedra citing the company's announcement that the FDA had issued a complete response letter for sotagliflozin to treat type 1 diabetes, consistent with his expectations. 5. Hibbett Sports (HIBB) upgraded to Positive from Neutral at Susquehanna. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/25/19
GABE
03/25/19
UPGRADE
GABE
Hold
Lexicon upgraded to Hold from Sell at Gabelli
Gabelli analyst Kevin Kedra upgraded Lexicon to Hold from Sell after the company announced that the FDA had issued a complete response letter for sotagliflozin to treat type 1 diabetes, consistent with his expectations. Kedra is raising his recommendation to Hold now that the negative catalyst of the CRL has past and the stock has pulled back by over 20%. Lexicon can now look towards a European launch of sotagliflozin and Phase 3 data readouts for the type 2 program in the second half of 2019, Kedra tells investors. He has 2020 private market value estimate of $6 per share for Lexicon.
03/25/19
STFL
03/25/19
NO CHANGE
Target $10
STFL
Buy
Lexicon price target lowered to $10 from $14 after CRL receipt at Stifel
Stifel analyst Stephen Willey has adjusted his model to a "substantially more-conservative scenario" for the launch of sotagliflozin for Type 1 diabetes following Lexicon's disclosure of its receipt of a Complete Response Letter, or CRL, from the FDA regarding its new drug application. He sees a lack of near-term visibility into what will be needed to satisfy the agency's concerns and now assumes a T1D commercial launch in the first half of 2021, Willey tells investors. He lowered his price target on Lexicon shares to $10 from $14 and admits that the near-term uncertainty "makes it increasingly difficult to stay positive on the stock," but Willey keeps a Buy rating as he sees multiple milestone-yielding data disclosures upcoming from the company's studies in Type 2 diabetes.
03/14/19
03/14/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lexicon (LXRX) downgraded to Sell from Hold at Gabelli with analyst Kevin Kedra citing his expectation that the FDA will reject sotagliflozin in type 1 diabetes by its March 22 PDUFA date following a split AdCom vote in January. 2. Sun Life Financial (SLF) downgraded to Underperformer from Neutral at CIBC. 3. Yum China (YUMC) downgraded to Outperform from Buy at Daiwa with analyst Adrian Chan citing valuation but says long-term growth remains intact. 4. Line Corp. (LN) downgraded to Underperform from Neutral at Credit Suisse. 5. Nabors Industries (NBR) downgraded to Neutral from Buy at Citi with analyst Scott Gruber saying Nabors' free cash flow outlook is weighted towards the second half of 2019, with Q1 likely to be a cash burn of $40M-plus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

06:45
05/27/19
05/27
06:45
05/27/19
06:45
General news
European stock marked moved broadly higher »

European stock marked…

05:50
05/27/19
05/27
05:50
05/27/19
05:50
General news
FX Update: Conditions have been thin »

FX Update: Conditions…

03:30
05/27/19
05/27
03:30
05/27/19
03:30
General news
FX Action: USD-CAD has settled in the mid 1.3400s »

FX Action: USD-CAD has…

03:00
05/27/19
05/27
03:00
05/27/19
03:00
General news
FX Update: Risk-off positioning have unwound some more in the forex markets »

FX Update: Risk-off…

02:35
05/27/19
05/27
02:35
05/27/19
02:35
General news
Asian Market Wrap: »

Asian Market Wrap:…

TEVA

Teva

$10.86

-0.18 (-1.63%)

12:11
05/26/19
05/26
12:11
05/26/19
12:11
Hot Stocks
Teva reaches $85M agreement with State of Oklahoma »

Teva Pharmaceuticals USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$141.85

1.33 (0.95%)

12:08
05/26/19
05/26
12:08
05/26/19
12:08
Hot Stocks
Elbit Systems awarded $127M contract to provide tactical radio system »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ADM

Archer Daniels

$39.17

-0.03 (-0.08%)

12:05
05/26/19
05/26
12:05
05/26/19
12:05
Hot Stocks
Archer Daniels expands recall of Baker's Corner All Purpose Flour 5lb bags »

ADM Milling is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.